spacer
home > pmps
PUBLICATIONS

Pharmaceutical Manufacturing and Packing Sourcer

 

Pharmaceutical Manufacturing and Packing Sourcer (PMPS) is a specialist journal designed to provide worldwide coverage of a range of topics relating to the pharmaceutical manufacturing and packaging sector.

Published quarterly, the journal functions as a platform of communication and information-sharing for executive and strategic decision-makers within the industry, identifying new trends and marketing opportunities as well as highlighting the latest innovations in this dynamic environment. PMPS is specifically designed to interest those in the pharmaceutical, biotech, nutritional and medical device industries who are actively seeking to source services for improved efficiency in what is an increasingly competitive market.


 

For further information please contact:

Advertising
Jonathan Smith

Editorial  
Angela Cottrell

We're also on Twitter! Follow us @PMPSmag  

Read our publications on the go in the Samedan app for iPhone and iPad. You can download issues for offline reading and our archives go as far back as 2008! Download for free on the App Store.


Click here to view the digital version of PMPS

 


  Click here to view the PMPS Inhalation Technology Supplement   
 

pmps
 
 
Featured in this issue
INHALATION TECHNOLOGY SUPPLEMENT
Self-Administration Devices

Training Session


Self-administered delivery devices are increasingly becoming the prevalent tools for patients’ drug therapies. Noble’s Jeff Miller elaborates on the resulting challenges in terms of adherence, and suggests that training devices can significantly boost patient outcomes.
Industry Insight
Industry Insight

PMPS
Industry Advisor Robert Harris highlights the need for basic medicines to be made available for the world's poor - one of the subjects of this edition. among other featured content, he also touches on key areas such as falsified medicines and patient adherence.
  Packaging, Packing and Anti-Counterfeiting
Product Design

Access All Areas


The ‘design for all’ concept is an innovative model that unifies the product design and service delivery needs of both pharma and patients. But how does it fare in the context of the developing world? Jane Berry at ColaLife investigates.

spacer
Edited by
Robert Harris
Chief Technical Officer at Juniper Pharma Services
Published quarterly in
February, May,
August and November


 
Industry Events

Pharma Supply and Logistics Innovation Program

6-7 June 2016, Hamburg, Germany

Pharma Supply and Logistics innovation program is a unique platform for 80+ Pharma and Biotech Companies with the collaborations of supply and logistics service providers.
More info >>

 
News and Press Releases

ICON selected by Genomics England to support the largest genome sequencing project of its kind for cancer and rare diseases


More info >>

Banner of Samedan app.PMPS on Samedan
air transport logo

 

White Papers

The Promise and Challenge of Adaptive Design in Oncology Trials

Medpace

Clinical oncology trials are more complex and time consuming than those in any other therapeutic area and failure rates are frustratingly high. Given the urgent need for new oncologic therapies, sponsors are eager to find more effective ways to conduct clinical research. Incorporating adaptive design methodologies into clinical trials can reduce costs and enhance efficiency while maintaining trial integrity. They can also reduce the number of patients on placebo and sub-therapeutic doses. In light of this promise, regulatory bodies have created guidelines supportive of adaptive design.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement